MetaADEDB 2.0 @ LMMD
Temozolomide
(BPEGJWRSRHCHSN-UHFFFAOYSA-N)
Structure
SMILES
NC(=O)c1ncn2c1nnn(c2=O)C
Type(s)
Approved; Investigational
ATC code(s)
L01AX03
Molecular Formula:
C6H6N6O2
Molecular Weight:
194.151
Log P:
-1.3778
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
1
TPSA:
108.17
CAS Number(s):
85622-93-1
Synonym(s)
1.
Temozolomide
2.
8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one
3.
CCRG 81045
4.
CCRG-81045
5.
M&B 39831
6.
M&B-39831
7.
Methazolastone
8.
NSC 362856
9.
NSC-362856
10.
TMZ-Bioshuttle
11.
TMZA-HE
12.
Temodal
13.
Temodar
14.
Temozolomide Hexyl Ester
15.
CCRG81045
16.
M&B39831
17.
NSC362856
18.
TMZ Bioshuttle
External Link(s)
MeSHD000077204
PubChem Compound5394
BindingDB50034562
ChEBI72564
CHEMBLCHEMBL810
DrugBankDB00853
DrugCentral2589
IUPHAR/BPS Guide to PHARMACOLOGY7301
KEGGdr:D06067
Therapeutic Target DatabaseD0C8EU
ZINC1482184
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 301
Canada Vigilance: 9
19107490CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
2ThrombocytopeniaFAERS: 296
Canada Vigilance: 21
17108062
20803286
CTD
SIDER
Canada Vigilance
US FAERS
3Disease ProgressionFAERS: 266
Canada Vigilance: 35
Canada Vigilance
OFFSIDES
US FAERS
4Drug ineffectiveFAERS: 222
Canada Vigilance: 35
Canada Vigilance
US FAERS
5FatigueFAERS: 190
Canada Vigilance: 13
19668033CTD
SIDER
Canada Vigilance
US FAERS
6VomitingFAERS: 186
Canada Vigilance: 7
19107490CTD
SIDER
Canada Vigilance
US FAERS
7PancytopeniaFAERS: 170
Canada Vigilance: 13
16648049
19668033
20684359
CTD
SIDER
Canada Vigilance
US FAERS
8PneumoniaFAERS: 152
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
9AstheniaFAERS: 135
Canada Vigilance: 11
Canada Vigilance
OFFSIDES
SIDER
US FAERS
10Malignant neoplasm progressionFAERS: 131
Canada Vigilance: 44
Canada Vigilance
OFFSIDES
US FAERS
11NeutropeniaFAERS: 124
Canada Vigilance: 9

View details

CTD
SIDER
Canada Vigilance
US FAERS
12Pulmonary EmbolismFAERS: 120
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
13White blood cell count decreasedFAERS: 108
Canada Vigilance: 9
Canada Vigilance
US FAERS
14HeadacheFAERS: 103
Canada Vigilance: 3
19107490CTD
SIDER
Canada Vigilance
US FAERS
15Febrile NeutropeniaFAERS: 96OFFSIDES
SIDER
US FAERS
16SepsisFAERS: 82US FAERS
17LeukopeniaFAERS: 79
Canada Vigilance: 1
16648049CTD
SIDER
Canada Vigilance
US FAERS
18General physical health deteriorationFAERS: 78
Canada Vigilance: 10
Canada Vigilance
OFFSIDES
US FAERS
19ConstipationFAERS: 73
Canada Vigilance: 4
19107490CTD
SIDER
Canada Vigilance
US FAERS
20GlioblastomaFAERS: 73
Canada Vigilance: 17

View details

CTD
OFFSIDES
Canada Vigilance
US FAERS
21Deep Vein ThrombosisFAERS: 71
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
22DehydrationFAERS: 66SIDER
US FAERS
23LymphopeniaFAERS: 65
Canada Vigilance: 2
17024124CTD
SIDER
Canada Vigilance
US FAERS
24Disease recurrenceFAERS: 63
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
25Adverse eventFAERS: 62
Canada Vigilance: 33
Canada Vigilance
US FAERS
26Product use in unapproved indicationFAERS: 52
Canada Vigilance: 14
Canada Vigilance
US FAERS
27InfectionFAERS: 49
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
28Inappropriate schedule of drug administrationFAERS: 48OFFSIDES
US FAERS
29No adverse eventFAERS: 45US FAERS
30Neutrophil count decreasedFAERS: 42
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
31Alanine Aminotransferase IncreasedFAERS: 41OFFSIDES
SIDER
US FAERS
32Glioblastoma MultiformeFAERS: 41
Canada Vigilance: 52
Canada Vigilance
OFFSIDES
US FAERS
33MalaiseFAERS: 41
Canada Vigilance: 15
Canada Vigilance
SIDER
US FAERS
34Mental status changesFAERS: 41US FAERS
35ThrombosisFAERS: 41
Canada Vigilance: 6
Canada Vigilance
US FAERS
36Weight decreasedFAERS: 40
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
37PainFAERS: 37
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
38Product use issueFAERS: 37
Canada Vigilance: 5
Canada Vigilance
US FAERS
39Abdominal PainFAERS: 36
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
40DizzinessFAERS: 36
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
41HemiparesisFAERS: 35
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
42AphasiaFAERS: 34
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
43HypotensionFAERS: 34US FAERS
44Aspartate Aminotransferase IncreasedFAERS: 33SIDER
US FAERS
45ChillsFAERS: 31SIDER
US FAERS
46Drug dose omissionFAERS: 31US FAERS
47HaematotoxicityFAERS: 31
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
48Memory impairmentFAERS: 31
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
49OverdoseFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
50Cerebrovascular accidentFAERS: 29
Canada Vigilance: 4
Canada Vigilance
US FAERS
51Pneumocystis jiroveci pneumoniaFAERS: 27OFFSIDES
US FAERS
52HydrocephalusFAERS: 26
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
53Lymphocyte count decreasedFAERS: 26
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
54PruritusFAERS: 26SIDER
US FAERS
55SomnolenceFAERS: 26
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
56Respiratory FailureFAERS: 25OFFSIDES
SIDER
US FAERS
57Toxicity to various agentsFAERS: 25
Canada Vigilance: 4
Canada Vigilance
US FAERS
58Urinary tract infectionFAERS: 25SIDER
US FAERS
59Incorrect dose administeredFAERS: 24
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
60ArthralgiaFAERS: 22SIDER
US FAERS
61EpistaxisFAERS: 22US FAERS
62LethargyFAERS: 21US FAERS
63TremorFAERS: 21SIDER
US FAERS
64AlopeciaFAERS: 20
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
65AnorexiaFAERS: 20OFFSIDES
SIDER
US FAERS
66SyncopeFAERS: 20US FAERS
67Therapy cessationFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
68Gamma-Glutamyltransferase IncreasedFAERS: 19OFFSIDES
SIDER
US FAERS
69HepatotoxicityFAERS: 19
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
70PneumonitisFAERS: 19US FAERS
71nervous system disorderFAERS: 19SIDER
US FAERS
72treatment failureFAERS: 19US FAERS
73AnxietyFAERS: 18SIDER
US FAERS
74Atrial FibrillationFAERS: 18US FAERS
75MyalgiaFAERS: 18SIDER
US FAERS
76UrticariaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
77BlindnessFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
78HemiplegiaFAERS: 17
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
79MYELODYSPLASTIC SYNDROMEFAERS: 17SIDER
US FAERS
80AgranulocytosisFAERS: 16US FAERS
81Anaplastic astrocytomaFAERS: 16
Canada Vigilance: 8
Canada Vigilance
OFFSIDES
US FAERS
82Cardiac ArrestFAERS: 16US FAERS
83Chest PainFAERS: 16US FAERS
84HypersensitivityFAERS: 16SIDER
US FAERS
85HypophagiaFAERS: 16OFFSIDES
US FAERS
86Radiation necrosisFAERS: 16
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
87Urinary IncontinenceFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
88Back PainFAERS: 15SIDER
US FAERS
89CellulitisFAERS: 15OFFSIDES
US FAERS
90Depressed Level of ConsciousnessFAERS: 15
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
91DisorientationFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
92HepatitisFAERS: 15OFFSIDES
SIDER
US FAERS
93PancreatitisFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
94Septic ShockFAERS: 15
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
95Acute kidney injuryFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
96Blood alkaline phosphatase increasedFAERS: 14SIDER
US FAERS
97Blood glucose increasedFAERS: 14US FAERS
98Blood lactate dehydrogenase increasedFAERS: 14OFFSIDES
US FAERS
99ColitisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
100DysarthriaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
101Product substitution issueFAERS: 14US FAERS
102Accidental exposure to productFAERS: 13US FAERS
103Accidental overdoseFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
104AmnesiaFAERS: 13
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
105Drug toxicityFAERS: 13US FAERS
106ErythemaFAERS: 1317495388CTD
SIDER
US FAERS
107PetechiaeFAERS: 13SIDER
US FAERS
108TachycardiaFAERS: 13US FAERS
109Bone painFAERS: 12US FAERS
110Cerebral InfarctionFAERS: 12US FAERS
111CholestasisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
112EmbolismFAERS: 12SIDER
US FAERS
113Product quality issueFAERS: 12US FAERS
114Radiation injuryFAERS: 12SIDER
US FAERS
115Wound InfectionFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
116Wrong technique in drug usage processFAERS: 12US FAERS
117jaundiceFAERS: 12US FAERS
118Bone marrow toxicityFAERS: 11OFFSIDES
US FAERS
119DeafnessFAERS: 11SIDER
US FAERS
120Drug administration errorFAERS: 11US FAERS
121Dry skinFAERS: 11SIDER
US FAERS
122DysgeusiaFAERS: 11SIDER
US FAERS
123Respiratory distressFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Acquired gene mutationFAERS: 10US FAERS
125Altered state of consciousnessFAERS: 10
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
126Disseminated Intravascular CoagulationFAERS: 10OFFSIDES
US FAERS
127Drug administered to patient of inappropriate ageFAERS: 10US FAERS
128EnterocolitisFAERS: 10US FAERS
129Medication ErrorFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
130NecrosisFAERS: 10
Canada Vigilance: 1
20045804CTD
Canada Vigilance
US FAERS
131Performance status decreasedFAERS: 10OFFSIDES
US FAERS
132Product dispensing errorFAERS: 10US FAERS
133Therapy changeFAERS: 10US FAERS
134Tumour haemorrhageFAERS: 10US FAERS
135Unevaluable eventFAERS: 10OFFSIDES
US FAERS
136Activities of daily living impairedFAERS: 9OFFSIDES
US FAERS
137AtaxiaFAERS: 9SIDER
US FAERS
138Blood albumin decreasedFAERS: 9OFFSIDES
US FAERS
139Blood creatinine increasedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
140Blood potassium decreasedFAERS: 9US FAERS
141Chest discomfortFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
142Facial paralysisFAERS: 9US FAERS
143Hospice CareFAERS: 9US FAERS
144PalpitationsFAERS: 9SIDER
US FAERS
145Peripheral swellingFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
146Platelet count abnormalFAERS: 9OFFSIDES
US FAERS
147SwellingFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
148Transfusion ReactionFAERS: 9OFFSIDES
US FAERS
149Wrong technique in product usage processFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
150AbasiaFAERS: 8OFFSIDES
US FAERS
151CD4 Lymphocytes DecreasedFAERS: 8OFFSIDES
US FAERS
152DeliriumFAERS: 8
Canada Vigilance: 1
17600176CTD
Canada Vigilance
US FAERS
153Diabetes InsipidusFAERS: 8US FAERS
154Drug dispensing errorFAERS: 8US FAERS
155Drug effect incompleteFAERS: 8US FAERS
156Drug exposure during pregnancyFAERS: 8US FAERS
157Full blood count decreasedFAERS: 8
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
158GastrostomyFAERS: 8US FAERS
159GliomaFAERS: 8

View details

CTD
US FAERS
160HypoxiaFAERS: 8US FAERS
161IncontinenceFAERS: 8US FAERS
162LeukoencephalopathyFAERS: 8US FAERS
163Meningitis herpesFAERS: 8OFFSIDES
US FAERS
164Myocardial InfarctionFAERS: 8US FAERS
165NasopharyngitisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
166PurpuraFAERS: 8SIDER
US FAERS
167ShockFAERS: 8US FAERS
168Status EpilepticusFAERS: 8SIDER
US FAERS
169Therapeutic response unexpectedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
170Therapy non-responderFAERS: 8
Canada Vigilance: 6
Canada Vigilance
US FAERS
171Transaminases increasedFAERS: 8US FAERS
172AstrocytomaFAERS: 7
Canada Vigilance: 1
15865885
16193384
20842591
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
173BedriddenFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
174CholelithiasisFAERS: 7US FAERS
175Cytolytic hepatitisFAERS: 7OFFSIDES
US FAERS
176Diverticular perforationFAERS: 7US FAERS
177Drug resistanceFAERS: 7US FAERS
178DysphasiaFAERS: 7OFFSIDES
SIDER
US FAERS
179EncephalomalaciaFAERS: 7OFFSIDES
US FAERS
180Feeling abnormalFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
181Incorrect route of drug administrationFAERS: 7US FAERS
182InflammationFAERS: 7US FAERS
183Lobar PneumoniaFAERS: 7US FAERS
184LymphadenopathyFAERS: 7US FAERS
185Night sweatsFAERS: 7US FAERS
186Oropharyngeal painFAERS: 7OFFSIDES
US FAERS
187PorokeratosisFAERS: 7US FAERS
188Respiratory arrestFAERS: 7US FAERS
189Stevens-Johnson SyndromeFAERS: 725811541CTD
SIDER
US FAERS
190Abdominal discomfortFAERS: 6US FAERS
191AbscessFAERS: 6US FAERS
192Anaphylactic shockFAERS: 6SIDER
US FAERS
193AngioedemaFAERS: 6SIDER
US FAERS
194Blood potassium increasedFAERS: 6OFFSIDES
US FAERS
195Blood sodium decreasedFAERS: 6US FAERS
196Bone marrow depressionFAERS: 6OFFSIDES
US FAERS
197BronchitisFAERS: 6OFFSIDES
SIDER
US FAERS
198CytopeniaFAERS: 6US FAERS
199DiverticulitisFAERS: 6OFFSIDES
US FAERS
200EcchymosisFAERS: 6US FAERS
201EpilepsyFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
202Escherichia infectionFAERS: 6OFFSIDES
US FAERS
203General physical condition abnormalFAERS: 6US FAERS
204Hypoglossal nerve paralysisFAERS: 6US FAERS
205Incorrect product storageFAERS: 6US FAERS
206LacerationFAERS: 6US FAERS
207Large intestine perforationFAERS: 6US FAERS
208Lipase increasedFAERS: 6US FAERS
209Lung consolidationFAERS: 6OFFSIDES
US FAERS
210MeningitisFAERS: 6US FAERS
211Mental impairmentFAERS: 6
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
212Musculoskeletal PainFAERS: 6SIDER
US FAERS
213Neutropenic sepsisFAERS: 6OFFSIDES
US FAERS
214Optic NeuritisFAERS: 6OFFSIDES
US FAERS
215Oral candidiasisFAERS: 6SIDER
US FAERS
216Palliative CareFAERS: 6
Canada Vigilance: 11
Canada Vigilance
US FAERS
217Peripheral motor neuropathyFAERS: 6US FAERS
218PolyuriaFAERS: 6US FAERS
219Product dose omissionFAERS: 6
Canada Vigilance: 7
Canada Vigilance
US FAERS
220SinusitisFAERS: 6SIDER
US FAERS
221Visual ImpairmentFAERS: 6
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
222Wound dehiscenceFAERS: 6US FAERS
223Acute respiratory failureFAERS: 5US FAERS
224AlveolitisFAERS: 5OFFSIDES
SIDER
US FAERS
225AtelectasisFAERS: 5OFFSIDES
US FAERS
226Central nervous system lesionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
227Circumstance or information capable of leading to medication errorFAERS: 5US FAERS
228Complex partial seizuresFAERS: 5US FAERS
229CystFAERS: 5US FAERS
230Diffuse Large B-Cell LymphomaFAERS: 5OFFSIDES
US FAERS
231DiplopiaFAERS: 5SIDER
US FAERS
232Drug ineffective for unapproved indicationFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
233Drug prescribing errorFAERS: 5US FAERS
234DyspepsiaFAERS: 5SIDER
US FAERS
235DysuriaFAERS: 5SIDER
US FAERS
236Escherichia sepsisFAERS: 5US FAERS
237Exposure via fatherFAERS: 5US FAERS
238Failure to ThriveFAERS: 5US FAERS
239Febrile bone marrow aplasiaFAERS: 5OFFSIDES
US FAERS
240HypertransaminasaemiaFAERS: 5US FAERS
241IleusFAERS: 5US FAERS
242Intracranial HypotensionFAERS: 5US FAERS
243Malignant GliomaFAERS: 5OFFSIDES
US FAERS
244MetastasisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
245Post procedural complicationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
246Pregnancy of partnerFAERS: 5US FAERS
247Pulmonary InfarctionFAERS: 5OFFSIDES
US FAERS
248Pulmonary thrombosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
249Retinal DetachmentFAERS: 5US FAERS
250Sputum culture positiveFAERS: 5OFFSIDES
US FAERS
251StomatitisFAERS: 5SIDER
US FAERS
252Unresponsive to stimuliFAERS: 5US FAERS
253Urine output increasedFAERS: 5OFFSIDES
US FAERS
254White blood cell count abnormalFAERS: 5US FAERS
255AgitationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
256Bacterial sepsisFAERS: 4OFFSIDES
US FAERS
257BlastomycosisFAERS: 4US FAERS
258Blood count abnormalFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
259Blood glucose abnormalFAERS: 4US FAERS
260Brain Stem GliomaFAERS: 4OFFSIDES
SIDER
US FAERS
261BronchiolitisFAERS: 4OFFSIDES
US FAERS
262Cerebral atrophyFAERS: 4OFFSIDES
US FAERS
263DementiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
264Diabetes MellitusFAERS: 4US FAERS
265DiplegiaFAERS: 4US FAERS
266Disease complicationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
267DiverticulumFAERS: 4US FAERS
268Gene MutationFAERS: 4US FAERS
269Grip strength decreasedFAERS: 4US FAERS
270HerniaFAERS: 4OFFSIDES
US FAERS
271HyperacusisFAERS: 4SIDER
US FAERS
272HypoventilationFAERS: 4US FAERS
273Inappropriate schedule of product administrationFAERS: 4
Canada Vigilance: 6
Canada Vigilance
US FAERS
274InfluenzaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
275Insurance issueFAERS: 4US FAERS
276Intestinal PerforationFAERS: 4US FAERS
277Intracranial AneurysmFAERS: 4US FAERS
278Intracranial massFAERS: 4US FAERS
279Lower respiratory tract infectionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
280Mutagenic effectFAERS: 4US FAERS
281NephrolithiasisFAERS: 4US FAERS
282NeuralgiaFAERS: 4US FAERS
283Neurological decompensationFAERS: 4OFFSIDES
US FAERS
284Neutrophil count abnormalFAERS: 4US FAERS
285Optic AtrophyFAERS: 4OFFSIDES
US FAERS
286Optic NeuropathyFAERS: 4US FAERS
287PregnancyFAERS: 4US FAERS
288Product administered to patient of inappropriate ageFAERS: 4US FAERS
289Product physical issueFAERS: 4US FAERS
290Product supply issueFAERS: 4US FAERS
291Product taste abnormalFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
292Productive CoughFAERS: 4OFFSIDES
US FAERS
293Protein total decreasedFAERS: 4OFFSIDES
US FAERS
294Pulmonary FibrosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
295Renal tubular necrosisFAERS: 4US FAERS
296RetchingFAERS: 4US FAERS
297Skin irritationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
298Skin reactionFAERS: 4US FAERS
299Supraventricular tachycardiaFAERS: 4OFFSIDES
US FAERS
300Vanishing bile duct syndromeFAERS: 4US FAERS
301Vascular occlusionFAERS: 4US FAERS
302Venous ThrombosisFAERS: 4US FAERS
303VertigoFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
304gliosarcomaFAERS: 420173548CTD
US FAERS
305AgeusiaFAERS: 3US FAERS
306Anal FistulaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
307Anaplastic OligodendrogliomaFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
308Apparent life threatening eventFAERS: 3OFFSIDES
US FAERS
309AppendicitisFAERS: 3US FAERS
310AspergillosisFAERS: 3OFFSIDES
US FAERS
311AsthmaFAERS: 3US FAERS
312Blood amylase increasedFAERS: 3US FAERS
313Blood creatine phosphokinase increasedFAERS: 3US FAERS
314Blood sodium increasedFAERS: 3US FAERS
315Blood urine presentFAERS: 3US FAERS
316BradycardiaFAERS: 3US FAERS
317Brain AbscessFAERS: 3
Canada Vigilance: 1
16757971CTD
Canada Vigilance
US FAERS
318CachexiaFAERS: 3US FAERS
319Central Nervous System InfectionFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
320Cheyne-Stokes RespirationFAERS: 3US FAERS
321ChromaturiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
322CystitisFAERS: 312393995CTD
US FAERS
323DermatitisFAERS: 3SIDER
US FAERS
324DysphoniaFAERS: 3US FAERS
325DysplasiaFAERS: 3US FAERS
326EosinophiliaFAERS: 3US FAERS
327Escherichia urinary tract infectionFAERS: 3OFFSIDES
US FAERS
328ExophthalmosFAERS: 3US FAERS
329Flank PainFAERS: 3OFFSIDES
US FAERS
330FractureFAERS: 3US FAERS
331Gait inabilityFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
332Hepatic congestionFAERS: 3OFFSIDES
US FAERS
333Hepatitis BFAERS: 3OFFSIDES
US FAERS
334Histiocytosis haematophagicFAERS: 3US FAERS
335HistoplasmosisFAERS: 3US FAERS
336HydropneumothoraxFAERS: 3OFFSIDES
US FAERS
337HypersomniaFAERS: 3US FAERS
338HyperventilationFAERS: 3US FAERS
339ImmunosuppressionFAERS: 3OFFSIDES
US FAERS
340Incorrect drug administration durationFAERS: 3US FAERS
341Intestinal ObstructionFAERS: 3US FAERS
342Limb discomfortFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
343Lymphocyte count abnormalFAERS: 3US FAERS
344Lymphocyte stimulation test positiveFAERS: 3US FAERS
345MenorrhagiaFAERS: 3SIDER
US FAERS
346Metabolic acidosisFAERS: 3OFFSIDES
US FAERS
347Metastatic NeoplasmFAERS: 3OFFSIDES
SIDER
US FAERS
348Muscle RigidityFAERS: 3US FAERS
349Muscle SpasticityFAERS: 3US FAERS
350MyositisFAERS: 3US FAERS
351Nephrogenic Diabetes InsipidusFAERS: 3OFFSIDES
US FAERS
352Pain of skinFAERS: 3US FAERS
353PharyngitisFAERS: 3SIDER
US FAERS
354Pharyngolaryngeal PainFAERS: 3OFFSIDES
US FAERS
355Plasmablastic lymphomaFAERS: 3US FAERS
356Prescribed overdoseFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
357Product distribution issueFAERS: 3US FAERS
358Product storage errorFAERS: 3US FAERS
359Product use complaintFAERS: 3US FAERS
360Pulmonary congestionFAERS: 3US FAERS
361PurulenceFAERS: 3US FAERS
362Rash erythematousFAERS: 3US FAERS
363Rectal abscessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
364Refusal of treatment by relativeFAERS: 3OFFSIDES
US FAERS
365Renal abscessFAERS: 3OFFSIDES
US FAERS
366Skin lesionFAERS: 3US FAERS
367Skin toxicityFAERS: 3US FAERS
368Soft Tissue InfectionFAERS: 3OFFSIDES
US FAERS
369Sudden deathFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
370Suicide attemptFAERS: 3US FAERS
371Terminal stateFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
372Tonic clonic movementsFAERS: 3US FAERS
373Transmission of drug via semenFAERS: 3US FAERS
374VasculitisFAERS: 315360003CTD
US FAERS
375skin abrasionFAERS: 3US FAERS
376Abdominal tendernessFAERS: 2OFFSIDES
US FAERS
377AcidosisFAERS: 2OFFSIDES
US FAERS
378AcneFAERS: 2US FAERS
379Acute pulmonary histoplasmosisFAERS: 2US FAERS
380Amniotic fluid index decreasedFAERS: 2US FAERS
381Anticonvulsant drug level below therapeuticFAERS: 2US FAERS
382ArthritisFAERS: 2US FAERS
383Arthropod biteFAERS: 2US FAERS
384Aspartate aminotransferase abnormalFAERS: 2US FAERS
385Autoimmune thrombocytopeniaFAERS: 2OFFSIDES
US FAERS
386B-cell unclassifiable lymphoma high gradeFAERS: 2US FAERS
387Bacterial test positiveFAERS: 2US FAERS
388Blood chloride decreasedFAERS: 2OFFSIDES
US FAERS
389Blood phosphorus decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
390Bone scan abnormalFAERS: 2OFFSIDES
US FAERS
391BradyphreniaFAERS: 2US FAERS
392Brain ContusionFAERS: 2US FAERS
393Brain scan abnormalFAERS: 2US FAERS
394BronchopneumoniaFAERS: 2US FAERS
395Bronchopulmonary AspergillosisFAERS: 2US FAERS
396Burning sensationFAERS: 2US FAERS
397CSF bacteria identifiedFAERS: 2US FAERS
398CandidiasisFAERS: 2US FAERS
399Capsule physical issueFAERS: 2US FAERS
400CardiotoxicityFAERS: 2US FAERS
401Catheter sepsisFAERS: 2US FAERS
402CholecystitisFAERS: 2US FAERS
403Cold sweatFAERS: 2US FAERS
404ConjunctivitisFAERS: 2US FAERS
405CraniotomyFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
406DiscomfortFAERS: 2SIDER
US FAERS
407Drug effective for unapproved indicationFAERS: 2US FAERS
408DysgraphiaFAERS: 2US FAERS
409EncephalitisFAERS: 2OFFSIDES
US FAERS
410Enterococcal infectionFAERS: 2US FAERS
411Enterocolitis bacterialFAERS: 2OFFSIDES
US FAERS
412Erectile dysfunctionFAERS: 2OFFSIDES
SIDER
US FAERS
413Erythema MultiformeFAERS: 2SIDER
US FAERS
414EuthanasiaFAERS: 2OFFSIDES
US FAERS
415Expired product administeredFAERS: 2US FAERS
416Exposure via body fluidFAERS: 2US FAERS
417Facial PainFAERS: 2US FAERS
418False positive investigation resultFAERS: 2US FAERS
419FlushingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
420Gastric pH decreasedFAERS: 2US FAERS
421GastritisFAERS: 2US FAERS
422Gastrointestinal perforationFAERS: 2US FAERS
423Gastrointestinal toxicityFAERS: 2US FAERS
424GlomerulonephritisFAERS: 2OFFSIDES
US FAERS
425GlycosuriaFAERS: 2US FAERS
426Granulocyte count increasedFAERS: 2US FAERS
427HepatosplenomegalyFAERS: 2OFFSIDES
US FAERS
428HypocapniaFAERS: 2US FAERS
429Impaired work abilityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
430Incision site infectionFAERS: 2US FAERS
431IncoherentFAERS: 2OFFSIDES
US FAERS
432Intentional drug misuseFAERS: 2US FAERS
433Liver AbscessFAERS: 2US FAERS
434Liver palpableFAERS: 2US FAERS
435Loss of personal independence in daily activitiesFAERS: 2US FAERS
436LymphomaFAERS: 2OFFSIDES
US FAERS
437Malignant melanoma stage IVFAERS: 2US FAERS
438Malignant transformationFAERS: 2US FAERS
439Medication residue presentFAERS: 2US FAERS
440Meningeal disorderFAERS: 2OFFSIDES
US FAERS
441MeningismFAERS: 2US FAERS
442Metabolic alkalosisFAERS: 2US FAERS
443Middle insomniaFAERS: 2US FAERS
444MonoparesisFAERS: 2US FAERS
445Musculoskeletal chest painFAERS: 2US FAERS
446MyelitisFAERS: 2OFFSIDES
US FAERS
447MyopathyFAERS: 2SIDER
US FAERS
448Nonspecific reactionFAERS: 2US FAERS
449Occupational exposure to productFAERS: 2US FAERS
450Oral painFAERS: 2US FAERS
451PallorFAERS: 2US FAERS
452Pancreatic PseudocystFAERS: 2US FAERS
453ParesisFAERS: 2SIDER
US FAERS
454Perirectal abscessFAERS: 2US FAERS
455Personality ChangeFAERS: 2US FAERS
456Platelet TransfusionFAERS: 2US FAERS
457Pleuritic painFAERS: 2US FAERS
458PolydipsiaFAERS: 2US FAERS
459Post procedural infectionFAERS: 2US FAERS
460Pre-EclampsiaFAERS: 2US FAERS
461Premature MenopauseFAERS: 2US FAERS
462PresyncopeFAERS: 2US FAERS
463Procedural complicationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
464ProctitisFAERS: 2US FAERS
465Product comminglingFAERS: 2US FAERS
466Product prescribing issueFAERS: 2US FAERS
467Pulmonary HypertensionFAERS: 2US FAERS
468Pulmonary artery thrombosisFAERS: 2US FAERS
469Pulmonary toxicityFAERS: 2US FAERS
470Purulent dischargeFAERS: 2US FAERS
471Quality of life decreasedFAERS: 2US FAERS
472Renal massFAERS: 2OFFSIDES
US FAERS
473Restless Legs SyndromeFAERS: 2US FAERS
474RestlessnessFAERS: 2US FAERS
475Retinal infarctionFAERS: 2US FAERS
476Secretion dischargeFAERS: 2US FAERS
477Shunt infectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
478Shunt malfunctionFAERS: 2US FAERS
479Sick Sinus SyndromeFAERS: 2OFFSIDES
US FAERS
480Skin lacerationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
481SoporFAERS: 2US FAERS
482Squamous cell carcinomaFAERS: 2US FAERS
483Staphylococcus test positiveFAERS: 2US FAERS
484Subdural EffusionFAERS: 2US FAERS
485Systemic mycosisFAERS: 2US FAERS
486ThirstFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
487TinnitusFAERS: 2SIDER
US FAERS
488TorticollisFAERS: 2US FAERS
489Toxic Epidermal NecrolysisFAERS: 2SIDER
US FAERS
490Troponin increasedFAERS: 2US FAERS
491Urinary RetentionFAERS: 2US FAERS
492Urinary tract infection fungalFAERS: 2OFFSIDES
US FAERS
493Ventricular DysfunctionFAERS: 2US FAERS
494Walking aid userFAERS: 2US FAERS
495White matter lesionFAERS: 2US FAERS
496furuncleFAERS: 2US FAERS
497Abdominal AbscessFAERS: 1US FAERS
498Abdominal massFAERS: 1US FAERS
499Accidental exposureFAERS: 1US FAERS
500Acquired porokeratosisFAERS: 1US FAERS
501Acute Coronary SyndromeFAERS: 1US FAERS
502Acute sinusitisFAERS: 1US FAERS
503Adenomatous Polyposis ColiFAERS: 1US FAERS
504AkinesiaFAERS: 1US FAERS
505Alanine aminotransferase abnormalFAERS: 1US FAERS
506Anaphylactoid ReactionFAERS: 1US FAERS
507AneurysmFAERS: 1US FAERS
508AngerFAERS: 1US FAERS
509Animal biteFAERS: 1US FAERS
510Antibiotic ProphylaxisFAERS: 1US FAERS
511Antibiotic therapyFAERS: 1US FAERS
512Antibody test positiveFAERS: 1US FAERS
513Anticonvulsant drug level decreasedFAERS: 1US FAERS
514Apallic syndromeFAERS: 1OFFSIDES
US FAERS
515ArthropathyFAERS: 1US FAERS
516AscitesFAERS: 1US FAERS
517AspergillomaFAERS: 1US FAERS
518Astrocytoma surgeryFAERS: 1US FAERS
519Atrial FlutterFAERS: 1US FAERS
520BRAF gene mutationFAERS: 1US FAERS
521Blast cell count increasedFAERS: 1US FAERS
522Blister ruptureFAERS: 1US FAERS
523Blood blisterFAERS: 1OFFSIDES
US FAERS
524Blood electrolytes abnormalFAERS: 1US FAERS
525Blood glucose decreasedFAERS: 1US FAERS
526Blood glucose fluctuationFAERS: 1US FAERS
527Blood osmolarity increasedFAERS: 1US FAERS
528Blood pH decreasedFAERS: 1US FAERS
529Blood potassium abnormalFAERS: 1US FAERS
530Blood pressure immeasurableFAERS: 1US FAERS
531Blood product transfusion dependentFAERS: 1OFFSIDES
US FAERS
532Blood triglycerides increasedFAERS: 1US FAERS
533Blood urea increasedFAERS: 1OFFSIDES
US FAERS
534Bone infarctionFAERS: 1OFFSIDES
US FAERS
535Bronchoalveolar lavage abnormalFAERS: 1US FAERS
536Capillary Leak SyndromeFAERS: 1US FAERS
537Cardiac enzymes increasedFAERS: 1US FAERS
538CardiomegalyFAERS: 1US FAERS
539Cardiovascular insufficiencyFAERS: 1US FAERS
540Catheter related infectionFAERS: 1US FAERS
541Catheter site infectionFAERS: 1OFFSIDES
US FAERS
542Cell DeathFAERS: 1US FAERS
543Central nervous system melanomaFAERS: 1US FAERS
544Cerebral ThrombosisFAERS: 1US FAERS
545Cerebral aspergillosisFAERS: 1US FAERS
546Cerebral cystFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
547Cerebral ventricle dilatationFAERS: 1OFFSIDES
US FAERS
548Cerebrospinal fluid reservoir placementFAERS: 1US FAERS
549CheilitisFAERS: 1US FAERS
550CholangitisFAERS: 1US FAERS
551Cholelithiasis obstructiveFAERS: 1US FAERS
552ChoreaFAERS: 1US FAERS
553ClaustrophobiaFAERS: 1US FAERS
554Clostridium difficile colitisFAERS: 1US FAERS
555Clostridium difficile infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
556ClumsinessFAERS: 1US FAERS
557ColectomyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
558Completed SuicideFAERS: 1US FAERS
559Complications of bone marrow transplantFAERS: 1US FAERS
560Coronary Artery DiseaseFAERS: 1US FAERS
561Creatinine renal clearance decreasedFAERS: 1US FAERS
562Culture positiveFAERS: 1US FAERS
563Culture urine positiveFAERS: 1US FAERS
564Cytoreductive SurgeryFAERS: 1US FAERS
565DNA mismatch repair protein gene mutationFAERS: 1US FAERS
566Deafness NeurosensoryFAERS: 1OFFSIDES
US FAERS
567DemyelinationFAERS: 1US FAERS
568Dental cariesFAERS: 1US FAERS
569Depressed moodFAERS: 1US FAERS
570Device malfunctionFAERS: 1US FAERS
571Diabetes mellitus inadequate controlFAERS: 1OFFSIDES
US FAERS
572Diabetic KetoacidosisFAERS: 1US FAERS
573Diastolic dysfunctionFAERS: 1OFFSIDES
US FAERS
574Double Outlet Right VentricleFAERS: 1US FAERS
575Duodenal UlcerFAERS: 1US FAERS
576DysacusisFAERS: 1US FAERS
577Echocardiogram abnormalFAERS: 1US FAERS
578Ejection Fraction DecreasedFAERS: 1US FAERS
579Electrocardiogram QRS complexFAERS: 1US FAERS
580Electrocardiogram abnormalFAERS: 1US FAERS
581Electroencephalogram abnormalFAERS: 1US FAERS
582Electrolyte depletionFAERS: 1US FAERS
583Electrolyte imbalanceFAERS: 1US FAERS
584Emergency CareFAERS: 1US FAERS
585Endometrial HyperplasiaFAERS: 1US FAERS
586EnuresisFAERS: 1US FAERS
587EpendymomaFAERS: 1US FAERS
588EscharFAERS: 1US FAERS
589Exfoliative rashFAERS: 1US FAERS
590Expired drug administeredFAERS: 1US FAERS
591Extra dose administeredFAERS: 1US FAERS
592Extracorporeal CirculationFAERS: 1US FAERS
593ExtravasationFAERS: 1US FAERS
594Eye InfectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
595Eye irritationFAERS: 1US FAERS
596Eye painFAERS: 1SIDER
US FAERS
597Fear of fallingFAERS: 1US FAERS
598Feeding tube userFAERS: 1US FAERS
599Feeling ColdFAERS: 1US FAERS
600Fluid imbalanceFAERS: 1US FAERS
601Fluid overloadFAERS: 1US FAERS
602Frustration tolerance decreasedFAERS: 1US FAERS
603Full blood count abnormalFAERS: 1US FAERS
604Fungus serology test positiveFAERS: 1US FAERS
605Fungus urine test positiveFAERS: 1US FAERS
606Gallbladder painFAERS: 1US FAERS
607GastroenteritisFAERS: 1SIDER
US FAERS
608Gastrointestinal infectionFAERS: 1OFFSIDES
US FAERS
609Glasgow coma scale abnormalFAERS: 1US FAERS
610GlaucomaFAERS: 1US FAERS
611Gram stain positiveFAERS: 1US FAERS
612Granulocyte count decreasedFAERS: 1US FAERS
613Hand-eye coordination impairedFAERS: 1US FAERS
614Head discomfortFAERS: 1US FAERS
615Hepatic EncephalopathyFAERS: 1US FAERS
616Hepatic enzyme decreasedFAERS: 1US FAERS
617Hepatic necrosisFAERS: 1US FAERS
618Hepatitis C RNA increasedFAERS: 1US FAERS
619Hepatitis CFAERS: 1US FAERS
620Hepatobiliary infectionFAERS: 1US FAERS
621HepatomegalyFAERS: 1US FAERS
622Herpes simplex serology positiveFAERS: 1US FAERS
623HirsutismFAERS: 1US FAERS
624HomicideFAERS: 1US FAERS
625HyperplasiaFAERS: 1US FAERS
626HyperpyrexiaFAERS: 1US FAERS
627Hypertensive crisisFAERS: 1US FAERS
628ImmobileFAERS: 1US FAERS
629Impaired driving abilityFAERS: 1US FAERS
630ImpatienceFAERS: 1US FAERS
631Incision site complicationFAERS: 1US FAERS
632Incision site painFAERS: 1OFFSIDES
US FAERS
633Incorrect storage of drugFAERS: 1US FAERS
634Infusion Site ExtravasationFAERS: 1US FAERS
635Intentional product use issueFAERS: 1US FAERS
636Intervertebral disc compressionFAERS: 1US FAERS
637Intestinal FistulaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
638Intestinal infarctionFAERS: 1OFFSIDES
US FAERS
639JC virus infectionFAERS: 1OFFSIDES
US FAERS
640Joint Range of Motion DecreasedFAERS: 1US FAERS
641Joint injuryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
642Joint stiffnessFAERS: 1US FAERS
643Joint swellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
644Klebsiella sepsisFAERS: 1US FAERS
645Laboratory test interferenceFAERS: 1US FAERS
646Lactose IntoleranceFAERS: 1US FAERS
647Lentigo maligna stage unspecifiedFAERS: 1US FAERS
648Lesion excisionFAERS: 1US FAERS
649Leukocytoclastic vasculitisFAERS: 1US FAERS
650Lip swellingFAERS: 1US FAERS
651Localised intraabdominal fluid collectionFAERS: 1US FAERS
652Lower gastrointestinal perforationFAERS: 1US FAERS
653Lung hyperinflationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
654Lymphatic system neoplasmFAERS: 1US FAERS
655Lymphocyte percentage increasedFAERS: 1US FAERS
656Malignant Fibrous HistiocytomaFAERS: 1US FAERS
657Mallory-Weiss SyndromeFAERS: 1OFFSIDES
US FAERS
658MalnutritionFAERS: 1SIDER
US FAERS
659MastoiditisFAERS: 1OFFSIDES
US FAERS
660Maternal exposure before pregnancyFAERS: 1US FAERS
661Maternal exposure during pregnancyFAERS: 1US FAERS
662Medical device site reactionFAERS: 1US FAERS
663MesotheliomaFAERS: 1OFFSIDES
US FAERS
664MetrorrhagiaFAERS: 1US FAERS
665Mineral deficiencyFAERS: 1US FAERS
666Mixed liver injuryFAERS: 1US FAERS
667MoaningFAERS: 1US FAERS
668MonoplegiaFAERS: 1US FAERS
669MosaicismFAERS: 1US FAERS
670Multiple SclerosisFAERS: 1US FAERS
671Muscle FatigueFAERS: 1US FAERS
672Musculoskeletal stiffnessFAERS: 1US FAERS
673MyocarditisFAERS: 1US FAERS
674Nasal discomfortFAERS: 1US FAERS
675Nephrotic SyndromeFAERS: 1US FAERS
676NervousnessFAERS: 1US FAERS
677Neuroblastoma recurrentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
678Neurological examination abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
679NeuropathyFAERS: 1SIDER
US FAERS
680Neutropenic infectionFAERS: 1US FAERS
681Neutrophil function disorderFAERS: 1OFFSIDES
US FAERS
682No adverse drug reactionFAERS: 1US FAERS
683No adverse effectFAERS: 1US FAERS
684NoduleFAERS: 1OFFSIDES
US FAERS
685Nutritional condition abnormalFAERS: 1US FAERS
686OliguriaFAERS: 1OFFSIDES
US FAERS
687Oncologic complicationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
688Oral pruritusFAERS: 1US FAERS
689Osmotic demyelination syndromeFAERS: 1US FAERS
690Osteitis DeformansFAERS: 1US FAERS
691OsteomyelitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
692Oxygen saturation abnormalFAERS: 1US FAERS
693Pancreatic carcinomaFAERS: 1US FAERS
694Panic DisorderFAERS: 1US FAERS
695ParanoiaFAERS: 1US FAERS
696ParaparesisFAERS: 1US FAERS
697ParotitisFAERS: 1US FAERS
698Pelvic InfectionFAERS: 1US FAERS
699Pelvic Inflammatory DiseaseFAERS: 1US FAERS
700Pelvic fluid collectionFAERS: 1US FAERS
701Pelvic venous thrombosisFAERS: 1US FAERS
702Pericardial effusionFAERS: 1US FAERS
703Peripheral embolismFAERS: 1US FAERS
704PeritonitisFAERS: 1US FAERS
705Pharmaceutical product complaintFAERS: 1US FAERS
706PhotophobiaFAERS: 1US FAERS
707PlasmapheresisFAERS: 1US FAERS
708Platelet adhesiveness increasedFAERS: 1US FAERS
709Pneumonia blastomycesFAERS: 1US FAERS
710PneumothoraxFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
711PoisoningFAERS: 1US FAERS
712PolyneuropathyFAERS: 1OFFSIDES
US FAERS
713Poor quality sleepFAERS: 1US FAERS
714Positron emission tomogram abnormalFAERS: 1US FAERS
715Postoperative renal failureFAERS: 1US FAERS
716Procedural hypotensionFAERS: 1US FAERS
717Procedural site reactionFAERS: 1US FAERS
718Product administration errorFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
719Product appearance confusionFAERS: 1US FAERS
720Product availability issueFAERS: 1US FAERS
721Product label issueFAERS: 1US FAERS
722Product packaging issueFAERS: 1US FAERS
723Protein total increasedFAERS: 1US FAERS
724ProteinuriaFAERS: 1US FAERS
725PseudomeningoceleFAERS: 1US FAERS
726Pseudomonal sepsisFAERS: 1OFFSIDES
US FAERS
727Psychiatric symptomFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
728Pulmonary Valve StenosisFAERS: 1US FAERS
729PyelonephritisFAERS: 1OFFSIDES
US FAERS
730Radiation interactionFAERS: 1US FAERS
731Radiation neuropathyFAERS: 1US FAERS
732Radiation skin injuryFAERS: 1US FAERS
733Reaction to drug excipientsFAERS: 1US FAERS
734Rectal tenesmusFAERS: 1US FAERS
735Refractory cancerFAERS: 1US FAERS
736Relapsing FeverFAERS: 1US FAERS
737Renal cystFAERS: 1US FAERS
738Respiratory DepressionFAERS: 1US FAERS
739Retinal Artery OcclusionFAERS: 1US FAERS
740RhonchiFAERS: 1US FAERS
741Right Ventricular DysfunctionFAERS: 1US FAERS
742ScreamingFAERS: 1US FAERS
743Simple Partial SeizuresFAERS: 1US FAERS
744Sinus TachycardiaFAERS: 1US FAERS
745Sinus headacheFAERS: 1US FAERS
746Skin UlcerFAERS: 1US FAERS
747Skin necrosisFAERS: 1US FAERS
748SluggishnessFAERS: 1US FAERS
749Soft tissue necrosisFAERS: 1US FAERS
750Speech rehabilitationFAERS: 1US FAERS
751SplenectomyFAERS: 1US FAERS
752Staphylococcal abscessFAERS: 1US FAERS
753StressFAERS: 1US FAERS
754StrongyloidiasisFAERS: 1US FAERS
755Subacute hepatic failureFAERS: 1US FAERS
756Subcutaneous AbscessFAERS: 1US FAERS
757SubileusFAERS: 1US FAERS
758SunburnFAERS: 1US FAERS
759Superinfection bacterialFAERS: 1US FAERS
760Superinfection fungalFAERS: 1US FAERS
761Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
762T-Cell LymphomaFAERS: 1US FAERS
763TachyarrhythmiaFAERS: 1US FAERS
764Therapeutic procedureFAERS: 1US FAERS
765Therapeutic product effect incompleteFAERS: 1US FAERS
766Therapeutic response changedFAERS: 1US FAERS
767Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
768Thermal burnFAERS: 1US FAERS
769Thoracic vertebral fractureFAERS: 1US FAERS
770ThrombophlebitisFAERS: 1OFFSIDES
SIDER
US FAERS
771Thrombosis in deviceFAERS: 1US FAERS
772Tooth LossFAERS: 1US FAERS
773ToothacheFAERS: 1US FAERS
774Transcription medication errorFAERS: 1US FAERS
775Transfusion-Related Acute Lung InjuryFAERS: 1US FAERS
776Traumatic fractureFAERS: 1US FAERS
777Trisomy 21FAERS: 1US FAERS
778TroponinFAERS: 1US FAERS
779TuberculosisFAERS: 1US FAERS
780UlcerFAERS: 1US FAERS
781Unhealthy dietFAERS: 1US FAERS
782Urinary tract inflammationFAERS: 1US FAERS
783UveitisFAERS: 1US FAERS
784VIIth nerve paralysisFAERS: 1US FAERS
785Vaginal DischargeFAERS: 1US FAERS
786Varicella Zoster Virus InfectionFAERS: 1US FAERS
787Vascular Access ComplicationFAERS: 1US FAERS
788Vasculitis gastrointestinalFAERS: 1US FAERS
789Venous thrombosis limbFAERS: 1US FAERS
790Ventricular FibrillationFAERS: 1US FAERS
791Vitreous DetachmentFAERS: 1US FAERS
792Vulvovaginal pruritusFAERS: 1US FAERS
793WheezingFAERS: 1US FAERS
794Wound ComplicationFAERS: 1US FAERS
795Wound infection bacterialFAERS: 1US FAERS
796Wound infection staphylococcalFAERS: 1US FAERS
797effusionFAERS: 1US FAERS
798keratoacanthomaFAERS: 1US FAERS
799leiomyosarcomaFAERS: 1OFFSIDES
US FAERS
800oligodendrogliomaFAERS: 1
Canada Vigilance: 3
20842591CTD
OFFSIDES
Canada Vigilance
US FAERS
801Abnormal pigmentationSIDER
802Abnormal plateletsSIDER
803Abnormal visionSIDER
804Abscess fungalOFFSIDES
805AcarodermatitisOFFSIDES
806Acid refluxOFFSIDES
807Acrodermatitis17495388CTD
808Acute prerenal failureOFFSIDES
809AdenocarcinomaOFFSIDES
810AdenoiditisOFFSIDES
811Adenoma20045804CTD
812Alveolar rhabdomyosarcomaCanada Vigilance: 1Canada Vigilance
813AmenorrheaOFFSIDES
814AmphetaminesOFFSIDES
815Anal abscessOFFSIDES
816Anemia15360003
17108062
CTD
817AnhidrosisOFFSIDES
818Anorectal cellulitisOFFSIDES
819Anticoagulant therapyCanada Vigilance: 1Canada Vigilance
820Antidepressant drug clearance decreasedOFFSIDES
821ApathySIDER
822AphagiaOFFSIDES
823AphoniaCanada Vigilance: 1Canada Vigilance
824ApneaOFFSIDES
825Apparent deathOFFSIDES
826ArteriosclerosisOFFSIDES
827Aseptic MeningitisOFFSIDES
828AsphyxiaOFFSIDES
829Aspiration PneumoniaOFFSIDES
830Bacillus infectionOFFSIDES
831Back disorderCanada Vigilance: 1Canada Vigilance
832Bacterial Infections12669766CTD
833Benign neoplasm of bladderOFFSIDES
834Biopsy bone marrow abnormalOFFSIDES
835Bladder neck obstructionOFFSIDES
836BlepharospasmOFFSIDES
837Blood albumin increasedOFFSIDES
838Blood alkaline phosphatase abnormalOFFSIDES
839Blood alkaline phosphatase decreasedOFFSIDES
840Blood and lymphatic system disordersSIDER
841Blood beta-D-glucan increasedOFFSIDES
842Blood bilirubin abnormalOFFSIDES
843Blood creatine increasedOFFSIDES
844Blood lactate dehydrogenaseOFFSIDES
845Blood pH increasedOFFSIDES
846Blood potassiumOFFSIDES
847Blood pressure orthostatic decreasedOFFSIDES
848Blood sodiumOFFSIDES
849Blood testosterone decreasedOFFSIDES
850Blunted affectOFFSIDES
851Bone Marrow Diseases17505778CTD
852Bone fissureOFFSIDES
853Brain Neoplasms15019092CTD
854Brain stem syndromeOFFSIDES
855Bronchial FistulaOFFSIDES
856Bronchoalveolar LavageOFFSIDES
857BronchopneumopathyOFFSIDES
858BursitisOFFSIDES
859Candida pneumoniaOFFSIDES
860Cardioactive drug level increasedOFFSIDES
861Cataract operationOFFSIDES
862CataractCanada Vigilance: 1Canada Vigilance
863Caustic injuryOFFSIDES
864Cerebral disorderCanada Vigilance: 1Canada Vigilance
865Chemical and Drug Induced Liver Injury27519711CTD
866Choking sensationOFFSIDES
867CholangiolitisOFFSIDES
868ChondromaOFFSIDES
869Chronic Obstructive Airway DiseaseOFFSIDES
870ClonusOFFSIDES
871Cognition Disorders17600176CTD
872Congenital pyelocaliectasisOFFSIDES
873Contusions19668033CTD
874CranioplastyCanada Vigilance: 1Canada Vigilance
875DebridementOFFSIDES
876DiabetesOFFSIDES
877Drug therapeutic incompatibilityOFFSIDES
878Dystrophic calcificationOFFSIDES
879Ear and labyrinth disordersSIDER
880EczemaCanada Vigilance: 1Canada Vigilance
881EncephalomyelitisCanada Vigilance: 1Canada Vigilance
882Eosinophil percentage increasedOFFSIDES
883Epidermal necrosisOFFSIDES
884EpiglottitisOFFSIDES
885Epstein-Barr virus test positiveOFFSIDES
886Esophageal Neoplasms21509778CTD
887Fatty LiverOFFSIDES
888Femoral arterial stenosisOFFSIDES
889Fever15360003CTD
890FibrinolysisOFFSIDES
891Flat affectOFFSIDES
SIDER
892Fungus sputum test positiveOFFSIDES
893GangreneOFFSIDES
894Gastrointestinal PainSIDER
895Gaze palsyOFFSIDES
896General physical conditionOFFSIDES
897Grip strengthOFFSIDES
898Guttate psoriasisOFFSIDES
899Hallucinations17600176CTD
900Heart Diseases15360003CTD
901Hemorrhage12393995
17505778
CTD
902Hepatitis B positiveOFFSIDES
903Human herpesvirus 8 infectionOFFSIDES
904HyperreflexiaOFFSIDES
905Infection in an immunocompromised hostOFFSIDES
906InfertilitySIDER
907InfestationSIDER
908Influenza-like symptomsSIDER
909Infusion site mobility decreasedOFFSIDES
910Intracranial meningioma malignantOFFSIDES
911Kidney FailureOFFSIDES
912LaryngitisCanada Vigilance: 1Canada Vigilance
913Leg edemaSIDER
914Leukopenia neonatalOFFSIDES
915LeukostasisOFFSIDES
916Listeria sepsisOFFSIDES
917Listeriosis16757971CTD
OFFSIDES
918Liver palpable subcostalOFFSIDES
919Lumbar puncture abnormalOFFSIDES
920Lung infiltration malignantOFFSIDES
921Lymphocyte percentage decreasedOFFSIDES
922LymphocytosisOFFSIDES
923MacrocytosisOFFSIDES
924Malignant ascitesOFFSIDES
925Malignant melanoma stage IOFFSIDES
926Manganese increasedOFFSIDES
927MedulloblastomaCanada Vigilance: 116243814
19107490
CTD
Canada Vigilance
928MeningiomaOFFSIDES
929Meningitis, Cryptococcal18398572CTD
930Mood swingsSIDER
931Musculoskeletal discomfortSIDER
932MyelodysplasiaOFFSIDES
933Myelodysplastic syndrome transformationOFFSIDES
934MyelosuppressionSIDER
935Myoclonic EpilepsyOFFSIDES
936Myoglobin blood increasedOFFSIDES
937Neoplasms, Experimental14506174
19363609
21509778
CTD
938NeuroblastomaCanada Vigilance: 115176712CTD
Canada Vigilance
939Neuropathic ulcerOFFSIDES
940New daily persistent headacheCanada Vigilance: 1Canada Vigilance
941Noninfective encephalitisCanada Vigilance: 1Canada Vigilance
942Open reduction of fractureOFFSIDES
943OphthalmoplegiaOFFSIDES
944Opportunistic Infections18398572CTD
945Oral fungal infectionOFFSIDES
946OsteolysisOFFSIDES
947OsteomaOFFSIDES
948Otitis MediaSIDER
949Pancreatic CystOFFSIDES
950Pancreatic enlargementCanada Vigilance: 1Canada Vigilance
951Paresthesia17495388CTD
952Pelvic abscessOFFSIDES
953Perivascular dermatitisOFFSIDES
954Pituitary Neoplasms20045804CTD
955PlasmacytosisOFFSIDES
956PneumoperitoneumOFFSIDES
957Poor peripheral circulationOFFSIDES
958PosturingOFFSIDES
959PyomyositisOFFSIDES
960Restrictive pulmonary diseaseOFFSIDES
961RhabdomyosarcomaCanada Vigilance: 1Canada Vigilance
962RhinitisOFFSIDES
963Right atrial dilatationOFFSIDES
964Scan abdomen abnormalOFFSIDES
965SclerodermaOFFSIDES
966ScotomaSIDER
967Serum amyloid A protein increasedOFFSIDES
968Shunt occlusionOFFSIDES
969Skin tightnessOFFSIDES
970Sleep Wake Disorders17600176CTD
971Splenic InfarctionOFFSIDES
972SuperinfectionCanada Vigilance: 1Canada Vigilance
973Superior Vena Cava SyndromeOFFSIDES
974Teratoma19107490CTD
975Therapeutic product effect decreasedCanada Vigilance: 2Canada Vigilance
976Therapy partial responderCanada Vigilance: 1Canada Vigilance
977Tinea VersicolorOFFSIDES
978TonsillitisOFFSIDES
979Traumatic liver injurySIDER
980Unresponsive to verbal stimuliOFFSIDES
981Urinary tract infection pseudomonalOFFSIDES
982Vaginal Neoplasms15577323CTD
983Vaginal ProlapseOFFSIDES
984Vascular compressionCanada Vigilance: 1Canada Vigilance
985Vascular purpuraSIDER
986Ventriculoperitoneal shunt malfunctionOFFSIDES
987Wound DebridementOFFSIDES
988cancer surgeryCanada Vigilance: 1Canada Vigilance
989intensive careCanada Vigilance: 1Canada Vigilance
990leukemia15360003
17500047
CTD
991melanoma

View details

CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.